Success Metrics

Active Trials

3(75%)

Phase Distribution

Ph phase_2

50%

Ph phase_3

25%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

2(50.0%)

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Detailed Status

Recruiting3

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Phase 22 (50.0%)

Phase 31 (25.0%)

N/A1 (25.0%)

Trials by Status

recruiting375%

not_yet_recruiting125%

Recent Activity

3 active trials

Showing 4 of 4

recruitingphase_3

A PAN-USR TB Multi-Center Trial

NCT06905522

recruitingphase_2

PanACEA - STEP2C -01

NCT05807399

recruitingphase_2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

NCT06114628

not_yet_recruitingnot_applicable

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

NCT07126639

Clinical Trials (4)

Showing 4 of 4 trials

NCT06905522Phase 3

A PAN-USR TB Multi-Center Trial

PanACEA - STEP2C -01

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Recruiting

NCT07126639Not Applicable

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Not Yet Recruiting

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4